Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: A Study of Olanzapine in Participants With Bipolar Disorder.

View source ↗

Summary

A clinical trial evaluating olanzapine in participants with bipolar disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Bipolar Disorder | Status: RECRUITING